🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

William R. Burns

Johns Hopkins University

ORCID: 0000-0002-3049-4377

Also affiliated with Johns Hopkins Medicine

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma”.

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma

Nature Communications(2023)10.1038/s41467-023-39196-9
N/A
1.4DataRank · unranked
87 citations

Carol Judkins, Keyu Li, Su Jin Lim, Jessica Hoare, Rose Parkinson +24 more

Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinoma

HPB(2020)10.1016/j.hpb.2020.08.016
N/A
0DataRank · unranked
24 citations

Shanshan Gao, Ross M. Beckman, Ding Ding, Michael Wright, Zhiyao Chen +15 more

Should non-invasive diffuse main-duct intraductal papillary mucinous neoplasms be treated with total pancreatectomy?

HPB(2021)10.1016/j.hpb.2021.09.013
N/A
0DataRank · unranked
12 citations

Ross M. Beckman, Joseph R. Habib, James F. Griffin, Kelly J. Lafaro, Richard A. Burkhart +6 more

Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.335
N/A
0DataRank · unranked
22 citations

Qingfeng Zhu, Jennifer N. Durham, Nicole Groß, Soren Charmsaz, James M. Leatherman +14 more

Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4165
N/A
0DataRank · unranked
88 citations

Jacquelyn W. Zimmerman, Reecha Suri, Haley Zlomke, Gabriel D. Ivey, Annamária Szabolcs +17 more

Limited English Proficiency and Clinical Outcomes After Hospital-Based Care in English-Speaking Countries: a Systematic Review

Journal of General Internal Medicine(2022)10.1007/s11606-021-07348-6
N/A
0DataRank · unranked
55 citations

Andrea Alonso, Swetha Duraiswamy, Carl Ceraolo, Timothy Feeney, Christine M. Gunn +4 more

Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.558
N/A
0DataRank · unranked
9 citations

Carol Judkins, Su Jin Lim, Hao Wang, Rose Parkinson, Jessica Gai +15 more

Data from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response

(2023)10.1158/1078-0432.c.6532688
N/A
0DataRank · unranked
0 citations

Jacquelyn W. Zimmerman, Reecha Suri, Haley Zlomke, Gabriel D. Ivey, Annamária Szabolcs +17 more

Data from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response

(2023)10.1158/1078-0432.c.6532688.v1
N/A
0DataRank · unranked
0 citations

Jacquelyn W. Zimmerman, Reecha Suri, Haley Zlomke, Gabriel D. Ivey, Annamária Szabolcs +17 more

Targeting heterogeneous tumor microenvironments in pancreatic cancer mouse models of metastasis by TGF-β depletion

JCI Insight(2024)10.1172/jci.insight.182766
N/A
0DataRank · unranked
15 citations

Heng‐Chung Kung, Birginia Espinoza, India Washington, Kai Chen, Jianxin Wang +9 more

Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer

HPB(2024)10.1016/j.hpb.2024.07.403
N/A
0DataRank · unranked
1 citations

Richard Zheng, Fabian M. Johnston, Jin He, William R. Burns, Christopher R. Shubert +3 more

The impact of a bloodless medicine program on pancreatic resections: A single-institution experience incorporating patients with borderline-resectable and locally advanced pancreatic cancer

Surgical Oncology Insight(2024)10.1016/j.soi.2024.100065
N/A
0DataRank · unranked
0 citations

Julia Purchla, N.C. Cruz, Ananda J. Thomas, Thomas McPhaul, Christopher R. Shubert +7 more

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-Up

Endocrine Pathology(2025)10.1007/s12022-025-09866-z
N/A
0DataRank · unranked
8 citations

Eric D. Young, Amanda L. Blackford, Pengfei Wu, Richard A. Burkhart, William R. Burns +14 more

Distinct response to IL-1β blockade in liver- and lung-specific metastasis mouse models of pancreatic cancer with heterogeneous tumor microenvironments

Experimental Hematology and Oncology(2025)10.1186/s40164-025-00607-w
N/A
0DataRank · unranked
7 citations

Heng‐Chung Kung, Birginia Espinoza, India Washington, Kai Chen, Kaiyi Mu +7 more

Rapidly progressive metastatic cholangiocarcinoma in a postpartum patient with cystic fibrosis: a case report

BMC Pulmonary Medicine(2020)10.1186/s12890-020-01337-x
N/A
0DataRank · unranked
5 citations

Kelly E. Craven, David W. Nauen, Kristina Montemayor, Mark Yarchoan, William R. Burns +3 more

The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinoma

Surgery(2025)10.1016/j.surg.2025.109611
N/A
0DataRank · unranked
0 citations

Joseph R. Habib, Benedict Kinny‐Köster, Julia Purchla, Jorge Franco, Aghnia J. Putri +16 more